论文信息 - Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases - 字舞流文

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

R. Greil | E. Winer | N. Lin | M. Campone | B. Kaufman | S. Rubin | D. Zembryki | K. Steplewski | S. Lane | W. Eierman